(Q68771168)
Statements
A phase I and pharmacokinetic study with 21-day continuous infusion of epirubicin (English)
J Greidanus
N H Mulder
M B Nieweg
D L Schipper
D T Sleijfer
D R Uges
1 September 1987
scientific article published on 01 September 1987